Literature DB >> 1695425

Inhibition of histamine release from human lung and rat peritoneal mast cells by cyclosporin-A.

I C Ezeamuzie1, E S Assem.   

Abstract

Cyclosporin A (CS-A) partly inhibited IgE-mediated histamine release from human lung tissue in vitro (chopped and collagenase-dispersed preparations). Inhibition started at concentrations within the clinical blood level of the drug, but the IC50 was much higher (10-50 microM; 50% inhibition reached only in some experiments). CS-A also inhibited histamine release from rat peritoneal mast cells (RPMC) induced by antigen, concanavalin-A (Con-A), compound 48/80 and ionophore A23187. The IC50 values were 0.3, 23.0, and 33.0 microM for Con-A, A23187 and ovalbumin respectively. Inhibition of 48/80-induced release did not reach 50%. By comparison with human basophils the human lung and RPMC were less sensitive to the inhibitory action of CS-A. The IgE-mediated Schultz-Dale reaction in human lung strips was slightly and inconsistently inhibited by CS-A, but IgG1-mediated reaction in guinea-pig lung strips was potentiated by the drug.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695425     DOI: 10.1007/bf01969012

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  9 in total

1.  Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.

Authors:  M Triggiani; R Cirillo; L M Lichtenstein; G Marone
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

2.  Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.

Authors:  A D Hess; P M Colombani
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

3.  Inhibition of the anaphylactic mechanism by sympathomimetic amines.

Authors:  E S Assem; H O Schild
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

4.  Pharmacologic and immunologic agonists and antagonists of cyclosporine.

Authors:  N L Tilney; T B Strom; J W Kupiec-Weglinski
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

5.  Inhibitory effect of cyclosporin A on histamine release from human leukocytes and rat mast cells.

Authors:  C Pedersen; H Permin; P Stahl Skov; S Norn; M Svenson; H Mosbech; K Bendtzen
Journal:  Allergy       Date:  1985-02       Impact factor: 13.146

6.  Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function.

Authors:  J J Burckhardt; B Guggenheim
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

7.  4 beta-PDBu contracts parenchymal strip and synergizes with raised cytosolic calcium.

Authors:  M M Dale; A W Obianime
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

8.  Histamine release from human pulmonary mast cells.

Authors:  M Ennis
Journal:  Agents Actions       Date:  1982-04

9.  Selective suppression of an early step in human B cell activation by cyclosporin A.

Authors:  A Muraguchi; J L Butler; J H Kehrl; R J Falkoff; A S Fauci
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

  9 in total
  3 in total

1.  Effect of cyclosporin-A on histamine release from tracheal strips of sensitized guinea pigs.

Authors:  M Bovingdon; E S Assem; B Y Wan
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

2.  Lack of inhibition by cyclosporin in the Schultz-Dale reaction.

Authors:  E S Assem; C I Ezeamuzie; B Y Wan; Y Ayalew
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

3.  Cyclosporine is angiostatic.

Authors:  K Norrby
Journal:  Experientia       Date:  1992-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.